CXCL12 and neoplasm: Seminal research by Orimo et al. highlighted the capacity of CAFs to drive tumor angiogenesis through increased production of SDF-1/CXCL12 compared to normal fibroblasts, thereby promoting recruitment and activation of progenitor ECs within the TME [75].